Enact Holdings, Inc.
NASDAQ:ACTInsurance - Specialty
+$0.07 today
- Market cap
- $6.05B
- Beta
- 0.48
- P/E (TTM)
- 8.9
- EPS (TTM)
- $4.78
- Dividend yield
- 2.04%
Volume 0.41M
Average 0.30M
ACT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Enact Holdings, Inc.NASDAQ: ACT
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue declines year over year
Q2 FY2026 cost of revenue of $33.26M fell 57.4% year over year, behind the -43.0% change in trailing-twelve-month cost of revenue. Sequentially, it fell 10.5% from the prior quarter. Over 3 fiscal years it compounded at -9.0% a year.
Context
- Cost of revenue amounted to 8.9% of revenue in FY2025, down 12.9 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -57.4% toward the trailing-twelve-month pace of -43.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 109.53M USD
- Year-over-year change
- -58.1%
- 4-year CAGR
- -26.3%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 109.53M | -58.1% |
| FY2024 | 2024-12-31 | 261.63M | +4.5% |
| FY2023 | 2023-12-31 | 250.31M | +72.5% |
| FY2022 | 2022-12-31 | 145.13M | -60.9% |
| FY2021 | 2021-12-31 | 371.63M | — |
Cost of Revenue vs competitors
How ACT compares with its peers on the latest reported figures
- ACT's LTM Jun 2026 cost of revenue of $176.97M is the 3rd highest of the 7 companies compared; the peer median is $67.98M.
- Its year-over-year change of -43.0% is the 6th highest of 7, against a peer median of +26.7%.
- Cost of revenue amounts to 14.1% of revenue for ACT, versus a peer median of 11.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $340.93M | +250.8% | — | 20.6% | |
| LTM Sep 2026 | $236.74M | +76.4% | — | 17.2% | |
| LTM Jun 2026 | $176.97M | -43.0% | -9.0% | 14.1% | |
| LTM Sep 2026 | $77.97M | +128.8% | — | 6.6% | |
| LTM Sep 2026 | $58M | -34.1% | +23.1% | 6.6% | |
| LTM Mar 2026 | $56M | -68.5% | +13.9% | 62.2% | |
| LTM Sep 2026 | $41.83M | -23.0% | — | 5.7% | |
| Peer median (excluding ACT) | $67.98M | +26.7% | +18.5% | 11.9% | |
Competitors are the stored peer set for ACT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.12B | 1.09B | 1.15B | 1.2B | 1.23B |
| Cost of Revenue | 371.63M | 145.13M | 250.31M | 261.63M | 109.53M |
| Gross Profit | 748.56M | 949.75M | 903.38M | 940.31M | 1.12B |
| Gross Margin | 66.8% | 86.7% | 78.3% | 78.2% | 91.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 53.34M | 51.53M | 51.87M | 62.25M | 262.02M |
| Depreciation & Amortization | 3.33M | 5.2M | 0 | 0 | 0 |
| EBITDA | 749.55M | 955.12M | 903.38M | 929.22M | 908.79M |
| EBITDA Margin | 66.9% | 87.2% | 78.3% | 77.3% | 73.9% |
| Operating Income | 695.22M | 898.22M | 851.51M | 878.06M | 858.84M |
| Operating Margin | 62.1% | 82.0% | 73.8% | 73.1% | 69.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 51.01M | 51.7M | 51.87M | 51.16M | 49.95M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 695.22M | 898.22M | 851.51M | 878.06M | 858.84M |
| Pre-Tax Margin | 62.1% | 82.0% | 73.8% | 73.1% | 69.8% |
| Income Tax Expense | 148.53M | 194.07M | 186M | 189.99M | 184.59M |
| Net Income | 546.69M | 704.16M | 665.51M | 688.07M | 674.24M |
| Net Margin | 48.8% | 64.3% | 57.7% | 57.2% | 54.8% |
| EPS (Basic) | 3.36 | 4.32 | 4.14 | 4.40 | 4.54 |
| EPS (Diluted) | 3.36 | 4.31 | 4.11 | 4.37 | 4.52 |
| Weighted Avg Shares | 162.84M | 162.84M | 160.87M | 156.28M | 148.37M |
| Weighted Avg Shares (Diluted) | 162.88M | 163.29M | 161.85M | 157.55M | 149.32M |
Enact Holdings, Inc.
NASDAQ:ACT
Intrinsic Alpha fair value
Locked
Current Price
$45.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.